期刊文献+

慢性肾脏病3-4期糖尿病肾脏疾病患者进展到终末期肾病的危险因素分类树模型分析 被引量:11

Classification Tree Model Analysis on Risk Factors of Diabetic Kidney Disease to Progress to ESRD for CKD3-4 Stages Patients
下载PDF
导出
摘要 【目的】分析糖尿病肾脏疾病(DKD)患者进展到终末期肾病(ESRD)的相关危险因素,筛查进展到ESRD的高风险人群,以早期预防。【方法】收集本院231例糖尿病肾脏疾病患者的临床资料,随访3年,据是否出现ESRD分为未进展到ESRD(133例)、ESRD组(98例)。使用分类树模型分析进展到ESRD相关危险因素,通过节点增益分析筛选进展到ESRD的高风险人群。【结果】从预测变量中筛选到4个重要解释变量:载脂蛋B(ApoB)、性别、糖尿病视网膜病变、收缩压;ApoB升高是DKD进展的重要的危险因素;ApoB>1.14mmol/L的慢性肾脏病(CKD)3~4期DKD患者,3年进展到ESRD的概率是75.0%,如合并糖尿病视网膜病变,有79.7%的概率进展到ESRD。【结论】分类树模型能有效筛选并分析进展到ESRD危险因素,并识别高风险人群特征,有利于早期防治。 【Objective】To analyze the risk factors of progression to end-stage renal disease(ESRD)in patients with diabetic kidney disease(DKD),and screen the high-risk population for early prevention.【Methods】The clinical data of 231 patients with diabetic nephropathy in our hospital were collected and followed up for 3 years. According to whether ESRD occurred,they were divided into non-progressing ESRD group(133 cases)and ESRD group(98 cases). Classification tree model was used to analyze the risk factors related to ESRD ,and the high-risk population was screened by node gain analysis.【Results】Four important explanatory variables were screened out by the classification tree model from the candidate variables related to early renal damage,including apolipoprotein B(ApoB),gender,diabetic retinopathy, systemic blood pressure(SBP). ApoB level was an important factor for DKD progression. For DKD patients with the chronic kidney disease (CKD)3~4 stages with ApoB > 1.14 mmol/L,the probability of progression to ESRD for 3 years was 75.0 %,and if at the same time with diabetic retinopathy,the probability was 79.7 %.【Conclusion】The classification tree model can analyze the risk factors of progression to ESRD in DKD patients effectively,to identify the characteristics of high-risk populations.
作者 廖志波 刘迅 成彩联 石成钢 李少敏 赵文波 LIAO Zhi-bo;LIU Xun;CHENG Cai-lian;SHI Cheng-gang;LIShao-min;ZHAO Wen-bo(Division of Nephrology,The Third Affiliated Hospital of Sun Yat-sen University Yuedong Hospital,Meizhou 514700,China;Department of Nephrology,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China)
出处 《中山大学学报(医学版)》 CAS CSCD 北大核心 2019年第5期767-773,共7页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省科技计划项目(2016A020215071) 广东省医学科研基金(A2016227) 梅州市社会发展科技计划专项(2017B128)
关键词 糖尿病肾脏疾病 分类树模型 危险因素 风险人群 diabetic kidney disease classification tree model risk factors risk populations
  • 相关文献

参考文献4

二级参考文献39

  • 1马冠生,朱丹红,胡小琪,栾德春,孔灵芝,杨晓光.中国居民饮酒行为现况[J].营养学报,2005,27(5):362-365. 被引量:195
  • 2马冠生,孔灵芝,栾德春,李艳平,胡小琪,王京钟,杨晓光.中国居民吸烟行为的现状分析[J].中国慢性病预防与控制,2005,13(5):195-199. 被引量:252
  • 3Fredrikson GN, Anand DV, Hopkins D, et al. Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes. Di- abtelogia, 2009, 52: 1426-1433. 被引量:1
  • 4Walldius G, Jungner I. The apoB apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy: a review of the evidence. J Intern Med, 2006, 259: 493-519. 被引量:1
  • 5Yamamoto T, Hirano T, Mori Y, et al. Significant increase of apolipoprotein 1348 levels by a standard test meal in type 2 dia- betic patients with nephropathy. J Atheroscler Thromb, 2008, 15: 199-205. 被引量:1
  • 6Tseng CH. Lipid abormalities associated with urinary albumin excretion rate in Taiwan Residents type 2 diabetic patients. Kidney In-ernational, 2005, 67: 1547-1553. 被引量:1
  • 7Miremadi S, Sniderman A, Frohlieh J. Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorder. Clin Chem, 2001, 48: 484-488. 被引量:1
  • 8Sniderman AD. Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice. J Clin Lipidol, 2008, 2: 36-42. 被引量:1
  • 9Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012,379(9818):815-822. 被引量:1
  • 10Parving HH, Lewis JB, Ravid M, et al. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective[J]. Kidney Int, 2006,69(11):2057-2063. 被引量:1

共引文献5761

同被引文献95

引证文献11

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部